NCT00102167已完成3 期
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study of MK0928 in Healthy Adult Volunteers Participating in a 4-Hour Phase Advance Model of Transient Insomnia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 663
- 主要终点
- Amount of time spent awake and time to fall asleep during one night
研究概览
简要总结
A study to evaluate the safety and effectiveness of Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia for insomnia (a sleep disorder).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy adults who are between the ages of 18 and 64
排除标准
- •Adults who are diagnosed with insomnia
结局指标
主要结局
Amount of time spent awake and time to fall asleep during one night
时间窗: one night
次要结局
- Amount of deep sleep during one night.(one night)
- Patient-reported sleep quality and awakenings during 1 night.(one night)
研究者
相似试验
已完成
3 期
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)InsomniaNCT00095069H. Lundbeck A/S600
已完成
3 期
Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)Major Depressive DisorderNCT00048594Merck Sharp & Dohme LLC800
已完成
3 期
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)Major Depressive DisorderNCT00035048Merck Sharp & Dohme LLC540
已完成
2 期
A Phase 2 Clinical Study of KHK4827Moderate to Severe Plaque PsoriasisNCT01748539Kyowa Kirin Co., Ltd.140
已完成
2 期
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)Paranoid SchizophreniaNCT00506077Merck Sharp & Dohme LLC55